Intranasal delivery of an adenovirus-vector vaccine co-expressing a modified spike protein and a genetic adjuvant confers lasting mucosal immunity against SARS-CoV-2
⚠︎Low quality — median 47 genes per cell. Datasets below 100 genes/cell may not produce meaningful analysis results.